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Abstract 
Background: Treatment with appropriate medication is a key factor to control hypertension and reduce the associ-
ated risk of complications. However, compliance with treatment is often sub-optimal, especially in developing coun-
tries. Our aim in this cross-sectional study is to investigate whether there is an association between sleep duration and 
treatment compliance among skilled professionals who are experiencing hypertension.
Methods: A questionnaire was given to all skilled professionals who are found hypertensive in an organization of 
Bangladesh. To assess treatment compliance, questions on self-reported compliance test were used. We collected 
information on self-reported short sleep duration (6 h or less) along with socio-demographic factors and clinical 
conditions of the subjects.
Results: Sleep duration is associated with compliance with treatment among hypertensive skilled professionals. We 
found overall associations of sleep duration (odds ratio (OR) 3.77, confidence interval 1.44–10.83) with treatment com-
pliance among hypertensive patients. In addition, body mass index (OR 1.19), marital status (OR 0.16) and duration of 
having hypertension are found significant factors for non-compliance with treatment.
Conclusion: There is an association between sleep duration and treatment compliance among the hypertensive 
patients. However, the study is conducted with a small group of skilled professionals from an organization and it is 
important to include multi-centers to validate the conclusion.
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Background
Blood pressure control remains an essential and continu-
ous approach to prevent the occurrence of coronary heart 
disease, heart failure, stroke and premature death [1]. It 
is also one of the most effective ways to retard the pro-
gression of diabetic and non-diabetic renal diseases [1]. 
Patient, non-compliance with treatment, has been recog-
nized as one of the major reasons why antihypertensive 
treatments fail. A study in USA supports the statement 
about failing of antihypertensive treatments failure 
because of non-compliance [2]. In a survey, non-compli-
ance was responsible for 17 % of treatment interruptions 
in Germany [3]. In Bangladesh, there were no such stud-
ies conducted till now. Therefore it is important to find 
the characteristic of the hypertensive populations who 
are non-compliant with the anti-hypertensive treatment. 
It will help to take necessary steps to this population to 
become compliant with the method of the treatment.
Non-compliance is very common among patients with 
a well-controlled blood pressure [4]. Thus, compliance is 
a very dynamic process; patients may adhere completely 
to their treatment for some periods of time and suddenly 
become noncompliant because of problems interfering 
with their treatments [5]. Therefore, compliance is a dif-
ficult parameter to assess clinically.
Duration of sleep plays an important role in good 
health and well being throughout everyone’s life. How-
ever, as a hallmark of modern society, sleep duration is 
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decreasing for adults in the last few decades [7]. Short 
sleep duration is associated with decreased levels of lep-
tin, glucose tolerance and insulin sensitivity, as well as 
increased levels of hunger and appetite [8]. Sleep restric-
tion could also affect exogenous factors such as food 
choice and increased time available to eat. Moreover, 
evidence suggests the relationship between short sleep 
and specific behavior, such as low physical activity and 
low consumption of fruit and vegetables [9]. Not many 
studies are conducted to see the affect of sleep duration 
on treatment compliance among hypertensive patients. 
Here our interest is to examine the affects of sleep loss 
on treatment compliance among a group of hypertensive 
patients.
Bangladesh Non-communicable disease (NCD) Risk 
Factor Survey in 2010 reported that, approximately 20 % 
of adult and 40 to 65  % of elderly people suffer from 
hypertension in Bangladesh [10]. Poor compliance with 
the treatment is very common among the Bangladesh 
population especially among the poor people. But, it is 
unknown why the treatment non-compliance is present 
among the hypertensive patients who do have formal 
education (at least attended the university) and who do 
have jobs as skilled professionals. This group of people 
can afford to buy medicine and can continue to control 
their hypertension. These motivate us to conduct a study 
to investigate among the hypertensive patients to find the 
factors associated with treatment non-compliance.
Methods
The data
The study was conducted in Intertek ltd., which is located 
at Dhaka, Bangladesh. There were about 512 skilled pro-
fessionals working in Intertek Dhaka, Bangladesh. Dur-
ing beginning of each year all the employees go through 
an employment health check up. From the history of the 
employee profiles we found 123 employees who were 
diagnosed as hypertensive patients for at least 6 months 
and they were prescribed for medication to control 
hypertension. These employees are educated who had a 
university education before joining in Intertek. We con-
ducted a population based cross-sectional survey among 
these skilled professionals and collected data for 101 
employees. Other 22 employees either declined to fill the 
questionnaire or they were on vacation during the survey. 
The Additional file 1 gives the data in excel format which 
can be downloaded from http://individual.utoronto.ca/
ahmed_3/index_files/data/data.html.
Compliance with treatment
Wong et  al. [11] delineated the treatment compliance 
when medical or health advice coincides with the indi-
vidual’s behavior with regard to the use of medication, 
recommended changes in lifestyle, and attendance to 
medical appointments. The Morisky et  al. [6] portrayed 
the treatment compliance in terms of four items coded 
as “yes” or “no”. These items relate to not taking medi-
cations due to carelessness, forgetting, feeling better, or 
feeling worse. Morisky et  al. [6] gave emphasis on for-
getting medication use to define the treatment compli-
ance which can be improved by a reminder from family 
members. We measured the compliance by asking three 
questions in a self-reported compliance test (SC) follow-
ing suggestions from the Morisky-Green test (MG) and 
Wong et al. [11]. The three questions include: (1) whether 
the patient continue with the medicine [6, 11], (2) 
whether the patient continue with regular clinic attend-
ance [11], and (3) whether the patient get social support 
from family members or friends who were concerned 
about the respondents hypertension or who were help-
ful in reminding the respondent about taking medication 
[6, 11]. The first question about compliance with medi-
cation is categorized as: “compliance: yes” (where the 
respondent ‘never misses’ or ‘rarely misses’ to take his/
her medication doses); and “compliance: no” (where the 
respondent ‘regularly’ or ‘fairly regularly’ misses to take 
his/her medication). All the questions are given a score 
of 1. Among these three questions we defined the com-
pliance with treatment as “yes” if an individual is found 
with total score of two including a positive response of 
the first question.
Independent variables
A self-reported questionnaire was designed to obtain 
information on gender, date of birth, height, weight, 
date of survey, marital status (married or unmarried), 
other health related problems (yes or no), family history 
of hypertension (yes or no), duration of hypertension, 
smoking habit (yes or no), duration of high blood pres-
sure and average daily sleep duration. Age was calculated 
in years from the date of births and body mass index 
(BMI) was calculated from the height and weight. The 
age and BMI were treated as continuous variables. The 
duration of hypertension was categorized as ≤1  years, 
2–3 years and ≥4 years. Sleep duration was assessed by 
the question, “How many hours each day do you spend 
sleeping?”. Sleep duration was categorized as short sleep 
duration (<6 h) and normal sleep duration (≥6 h). From 
August to September 2015, inspectors who were familiar 
with the questionnaire went to Intertek and distributed 
the questionnaire among the skilled professionals who 
were known to have hypertension for at least 6  months 
and taking medication to control it. Any question or con-
fusion from the participants was clarified to ensure that 
everyone understood all of the items. The completed 
questionnaires were checked for quality control.
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Ethical approval
Ethical approval for the study protocol was obtained 
from the North South University Review Committee 
and Intertek, Dhaka and a written informed consent was 
obtained from all the participants.
Statistical analysis
We analyzed the data using software R. Descriptive sta-
tistics were calculated for all of the variables, including 
continuous variables (presented as boxplots) and cat-
egorical variables (presented as frequencies). The unad-
justed association between each of categorical variables 
and treatment compliance was evaluated by Chi square 
test. The association between sleep duration and treat-
ment compliance was estimated by multivariable logistic 
regression models, which were adjusted for age, gender, 
marital status, BMI, other health problem, family history 
of hypertension, smoking status and duration of high 
blood pressure into the model. The results were reported 
by odds ratios (ORs) and corresponded 95 % confidence 
intervals (CIs). P-values less than 0.05 were considered 
statistically significant.
Results
The data comprised 101 skilled workers aged 25–51 years 
(mean 38.27  years, 72.27  % male). The baseline charac-
teristics of the participants, such as sex, marital status, 
family history of hypertension, other health problems, 
current smoking status, sleep duration and duration of 
blood pressure, are described (see Table  1). Compared 
with a female, a male had a higher prevalence of non-
compliant, but the p value does not indicate sex has any 
significant effect on compliance (p  >  0.05, Table  1). No 
variable is found significant on compliance with treat-
ment considering 5 % significance level. The age and BMI 
are considered as a continuous variable and the boxplots 
for age and BMI corresponding to compliance level are 
given in the Fig. 1. It appears from the Fig. 1 (boxplot for 
age) that younger individuals are more compliant about 
treatment to control hypertension compared to the 
older people. Again, the boxplot for BMI indicates that 
weighted individuals are more non-compliant with treat-
ment compared to those who have less BMI. The figure 
shows that the most persons who are having BMI greater 
than 30 are in the non-compliant group.
Moreover, sleep duration is related to obesity [12, 13]. 
Therefore, it is important to stratify obesity to avoid the 
confounding effect in the analysis. We found the correla-
tion between age and BMI is 0.14, which indicates a weak 
relationship between age and BMI, and therefore BMI is 
not considered as a confounding variable in this study. 
Here we considered BMI as a continuous variable and 
continued our multivariate analysis without stratification 
by obesity.
We fit a multivariable logistic regression model with 
treatment compliance levels after adjusting all the 
potential risk factors. The adjusted odds ratios (ORs) for 
compliant group are given in Table 2. It appears that the 
95 % confidence interval of sleep duration (OR = 3.776, 
CI  =  1.445, 10.834) is not including the value 1 and 
therefore it is a significant variable. In fact, the p-value 
is found 0.009, which indicates a significant relationship 
between, sleep duration and treatment compliance at 
5 % significance level. Again, the odds ratio explains that 
the odds of being non-compliant are 3.78 times more 
for the long sleep duration group compared to the group 
who sleep less than 6  h. It is expected because many 
patients may feel well of having a long sleep and they 
may have a negative attitude towards taking medication. 
In addition, the marital status (OR = 0.157, CI = 0.024, 
0.789; p-value = 0.034) and BMI (OR = 1.19, CI = 1.05, 
1.3; p-value  =  0.008) are found significant. The mar-
ried professionals are about 80  % less likely to be 
treatment compliant compared to the unmarried pro-
fessionals. Again, one unit increase of BMI indicates 
18  % more likely to be treatment compliant to control 
hypertension.
Table 1 Participant characteristic by  treatment compli-







Sex F 14 14 0.701 0.402
M 28 45
Marital status Married 38 45 2.48 0.115
Unmarried 4 14
Other health problems No 16 27 0.318 0.572
Yes 26 32
Family history Negative 13 14 0.336 0.561
Positive 29 45
Smoking No 30 43 0 1
Yes 12 16
Sleep hour 6 h 28 28 2.928 0.087
<6 h 14 31
Use of sleep drug No 28 41 0.007 0.933
Yes 14 18
Duration of hypertension 1 year 7 7
2–3 years 17 23 0.631 0.729
4 years 18 29
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Fig. 1 Boxplot of Age and BMI corresponding to compliance levels
Table 2 Adjusted relationships between covariates and treatment compliance that is analyzed using logistic regression
OR odds ratio
LCL 95 % Lower confidence limit of OR
UCL 95 % Upper confidence limit of OR
Variable Reference Estimate OR LCL UCL p value
Age 0.036 1.036 0.936 1.151 0.495
Sex- female Male −0.383 0.682 0.225 2.054 0.494
Marital status- married Unmarried −1.851 0.157 0.024 0.789 0.034
BMI 0.173 1.189 1.052 1.364 0.008
Other problem Yes −0.38 0.684 0.209 2.168 0.521
Family history Positive −0.538 0.584 0.2 1.657 0.313
Smoking- no Yes 0.854 2.348 0.79 7.285 0.129
Sleep hour- short Long (>6 h) 1.329 3.776 1.445 10.834 0.009
Duration of hypertension- 2–3 Y 1 Y −1.656 0.191 0.028 1.052 0.069
Duration of Hypertension- 4 Y 1 Y −1.743 0.175 0.027 0.916 0.049
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Discussions and conclusion
Treatment with appropriate medication and compli-
ance with the treatment are key factors in the control of 
hypertension. The failure to control hypertension takes 
an undesirable toll on patients and their families. Non-
compliance with treatment has a cost as it leads to an 
increase in medical expenses and it decreases the cost 
effectiveness of the interventions. Therefore, it is impor-
tant to identify the hypertensive patients who are at 
risk of non-compliance with treatment. In this study we 
found, patients with long sleep duration are more non-
compliant with treatment among the skilled hyperten-
sive professionals. In addition, unmarried patients are 
more non-compliant with the treatment of hypertension. 
Obese patient tend to be more treatment non-compliant 
than the normal weight patients. Therefore, it is impor-
tant to give attention to overweight and obese patients so 
that they can be treatment compliant to control hyper-
tension. Consideration should also be given to long-term 
hypertensive patients. There is a tendency among the 
long-term hypertensive patients of poor adherence to the 
treatment and want to avoid clinician’s advice. In con-
clusion, our attention should be focused on unmarried, 
obese patients who have a habit of long sleep duration 
so that they can take a suitable treatment plan to con-
trol hypertension. The study involves a relatively small 
number of participants, which means additional studies 
need to be conducted in order to define more precisely 
the hypertensive populations which are the most likely to 
benefit from monitoring.
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